Chennai, Oct. 14 -- The Tamil Nadu government on Monday revoked the manufacturing licence of Sresan Pharmaceuticals that produced the now-banned contaminated cough syrup Coldrif, which is linked to the deaths of several children in Madhya Pradesh, an official statement said. The Tamil Nadu health department has also ordered comprehensive inspections across all pharmaceutical manufacturing units in the state, with officials saying statewide inspections were underway. Meanwhile, the World Health Organization (WHO) issued a health advisory warning about three contaminated cough syrups identified in India, including Coldrif, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals and Shape Pharma. "The drug manufacturing license of Sresan Pharmaceuticals has been completely cancelled, and the company has been closed. Orders have been given to conduct a detailed inspection of other drug manufacturing companies located in Tamil Nadu," the state health department said. P9...